On 14 November 2016
Relish Pharmaceuticals announced that the meeting of the Board of Directors of the Company will be held on 14 November 2016 inter alia, to transact the following business:- To consider, adopt and approve Unaudited Financial Results for the quarter ended on 30 September 2016.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content